Evolent Health (EVH) Earnings Analysis
Evolent Health (EVH) has no confirmed upcoming earnings date. Last quarter (2026-05-07) it beat with EPS -0.02 USD vs -0.05 USD est (+60%). It has beaten estimates in 2/5 recent quarters (40%). Trailing P/E -1.19.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does EVH next report earnings?
No confirmed upcoming earnings date is currently scheduled for EVH. This page updates as the calendar is published.
EVH earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | -0.02 USD | -0.05 USD | +60% | Beat |
| 2025-11-06 | 0.05 USD | 0.1 USD | -50% | Miss |
| 2025-08-07 | -0.1 USD | 0.09 USD | -211.1% | Miss |
| 2025-02-20 | -0.02 USD | 0.38 USD | -105.3% | Miss |
| 2024-08-08 | 0.3 USD | 0.21 USD | +42.9% | Beat |
Beat rate: 2/5 (40%) over reported quarters with consensus data.
EVH valuation and analyst view
| Trailing P/E | -1.19 |
|---|---|
| Trailing EPS | -4.43701 USD |
| Price / book | 1.57 |
| Dividend yield | 0.00% |
| Market cap | 0.63B |
| Analyst consensus | Buy (22 buy / 7 hold / 0 sell) |
| Avg price target | 6.67 USD |
Related research pages
Frequently asked questions
When is Evolent Health (EVH)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for EVH. This page updates as the calendar is published.
Did EVH beat earnings last quarter?
In its 2026-05-07 report, EVH posted EPS of -0.02 USD versus a -0.05 USD estimate — a beat of 60%.
What is EVH's earnings track record?
Over the last 5 reported quarters with consensus data, EVH beat estimates 2 times (40%).
What is EVH's current P/E ratio and EPS?
EVH trades at a trailing P/E of -1.19 on trailing EPS of -4.437013538269068 USD.
What do analysts rate EVH?
Analyst consensus is "Buy" across 29 ratings (0 strong buy, 22 buy, 7 hold, 0 sell, 0 strong sell). Average 12-month price target: 6.67 USD.